The Paediatric Sepsis Priority Setting Partnership (PSP) has been established to identify the most urgent unanswered questions about sepsis in children and to set priorities for future research. This work is guided by the James Lind Alliance (JLA), an initiative that brings together patients, carers, and clinicians to shape research agendas around issues that matter most to those directly affected.
The scope will include infants and children from 1 week of life to 18 years of life.
The PSP is a global initiative focusing on both high and low middle income countries.
The PSP will use surveys to determine a Top 10 list of key research priorities in sepsis care for children and inform the Paediatric Adaptive Sepsis Platform Trial (PASSPORT). By ensuring the trial answers the questions that matter most, we can accelerate progress and improve outcomes for critically ill children worldwide.
Your support is needed to promote Survey 1 to ensure we receive a diverse response from across the globe.
How you can help:
- Take the survey — share your perspective as a health care professional, researcher, patient, or carer.
- Share widely — help us reach families, clinicians, and communities in your networks.
- Use our toolkit — ready-to-use posts, images, and messages are available.
Use the toolkit — ready-to-use posts, images, and messages are available.
